Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_assertion type Assertion NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_head.
- NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_assertion description "[Sixty-one transplanted patients who had IgAN as an original disease (30 with biopsy-proved early recurrence, median 2.9 yr post-transplant), and 120 controls, were investigated for aberrantly glycosylated IgA1, IgA binding to mesangial matrix, macromolecular IgA (IgA/fibronectin and uteroglobulin/IgA/fibronectin complexes), and polymorphisms of cytokines [tumor necrosis factor alpha (TNFalpha), interleukin 10 (IL-10), IL-6, interferon gamma and transforming growth factor beta 1] and renin-angiotensin system (angiotensinogen converting enzyme, angiotensin II receptor 1, and angiotensinogen) genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_provenance.
- NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_assertion evidence source_evidence_literature NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_provenance.
- NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_assertion SIO_000772 17988266 NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_provenance.
- NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_assertion wasDerivedFrom befree-20140225 NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_provenance.
- NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_assertion wasGeneratedBy ECO_0000203 NP344691.RAMllNOqs2KFem-EKbzWjKbZW_PAJIyrhtgF_J8JRVOJ0130_provenance.